SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-581023
Filing Date
2016-05-06
Accepted
2016-05-06 08:36:03
Documents
4
Period of Report
2016-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193433d8k.htm 8-K 20355
2 EX-10.1 d193433dex101.htm EX-10.1 16723
3 EX-99.1 d193433dex991.htm EX-99.1 8881
4 GRAPHIC g193433g0506125351413.jpg GRAPHIC 2932
  Complete submission text file 0001193125-16-581023.txt   51395
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 161625994
SIC: 2834 Pharmaceutical Preparations